Murphy Dl
Impact in
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
- Behavioral Neuroscience top 10%
- Stress Responses and Cortisol
Papers in
-
- Neurotransmitter Receptor Influence on Behavior 9
- Neuroscience and Neuropharmacology Research 3
-
- Treatment of Major Depression 6
- Co-authors
- Goodwin Fk (2 shared papers)William Edward Bunney (2 shared papers)H. Keith H. Brodie (1 shared paper)Cohen Rm (6 shared papers)John R. Glowa (1 shared paper)Megan Altemus (1 shared paper)Trey Sunderland (4 shared papers)Herbert Weingartner (3 shared papers)
- Journals
- PubMed (27 papers)
- Partner nations
- United States
In The Last Decade
Murphy Dl
28 papers receiving 482 citations
Peers
Comparison fields: 5 of 55
- Biological Psychiatry 37
- Behavioral Neuroscience 46
- Cellular and Molecular Neuroscience 176
- Pharmacology 159
- Psychiatry and Mental health 158
Countries citing papers authored by Murphy Dl
This map shows the geographic impact of Murphy Dl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murphy Dl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murphy Dl more than expected).
Fields of papers citing papers by Murphy Dl
This network shows the impact of papers produced by Murphy Dl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murphy Dl. The network helps show where Murphy Dl may publish in the future.
Co-authors
The 25 scholars most cited alongside Murphy Dl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients. | 1970 | 168 |
| 2 | New contributions from basic science to understanding the effects of monoamine oxidase inhibiting antidepressants. | 1984 | 78 |
| 3 | Use of serotonergic agents in the clinical assessment of central serotonin function. | 1986 | 59 |
| 4 | Attenuation of food-restriction-induced running by chronic fluoxetine treatment. | 1993 | 40 |
| 5 | Cholinomimetic-induced co-release of prolactin and beta-endorphin in man. | 1982 | 32 |
| 6 | L-dopa, behavioral activation and psychopathology. | 1972 | 28 |
| 7 | Cognitive and behavioral sensitivity to scopolamine in Alzheimer patients and controls. | 1985 | 19 |
| 8 | A new postsynaptic serotonin receptor agonist suitable for studies in humans. | 1985 | 18 |
| 9 | Serotonergically induced hormonal responses and the antidepressant effect of total sleep deprivation in patients with major depression. | 1988 | 15 |
| 10 | Clinical and laboratory studies with selective monoamine-oxidase-inhibiting drugs. Implications for hypothesized neurotransmitter changes associated with depression and antidepressant drug effects. | 1983 | 14 |
| 11 | Neurotransmitter-related enzymes in the major psychiatric disorders: I. Catechol-O-methyl transferase, monoamine oxidase in the affective disorders, and factors affecting some behaviorally correlated enzyme activities. | 1975 | 13 |
| 12 | Antiobsessional and antidepressant effects of clomipramine in the treatment of obsessive-compulsive disorder. | 1982 | 13 |
| 13 | Disturbances of norepinephrine metabolism and alpha-2 adrenergic receptor activity in anorexia nervosa: relationship to nutritional state. | 1985 | 13 |
| 14 | Neurotransmitter-related enzymes in the major psychiatric disorders: II. MAO and DBH in schizophrenia. | 1975 | 12 |
| 15 | Low- and high-dose naloxone in dementia of the Alzheimer type. | 1985 | 11 |
| 16 | Effects of a selective inhibitor of type A monoamine oxidase--Lilly 51641--on behavior, sleep and circadian rhythms in depressed and schizophrenic patients. | 1978 | 8 |
| 17 | Effects of drug states and clinical phenomena on the storage and retrieval of information in man [proceedings]. | 1977 | 7 |
| 18 | Sleep disturbance in depression: diagnostic potential and pathophysiology [proceedings]. | 1980 | 6 |
| 19 | Platelet monoamine oxidase activity and human sleep. | 1978 | 5 |
| 20 | Alterations in noradrenergic function during clorgyline treatment. | 1980 | 5 |
About Murphy Dl
Murphy Dl is a scholar working on Cellular and Molecular Neuroscience, Pharmacology, Psychiatry and Mental health, Clinical Psychology and Biological Psychiatry, having authored 28 papers that have together received 580 indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (9 papers), Treatment of Major Depression (6 papers), Obsessive-Compulsive Spectrum Disorders (4 papers), Alzheimer's disease research and treatments (3 papers), Dementia and Cognitive Impairment Research (3 papers), Neuroscience and Neuropharmacology Research (3 papers), Schizophrenia research and treatment (2 papers) and Circadian rhythm and melatonin (2 papers). The work is most often cited by research in Biological Psychiatry (37 citations), Behavioral Neuroscience (46 citations), Cellular and Molecular Neuroscience (176 citations), Pharmacology (159 citations) and Psychiatry and Mental health (158 citations). Murphy Dl has collaborated with scholars based in United States. Frequent co-authors include Goodwin Fk, William Edward Bunney, H. Keith H. Brodie, Cohen Rm, John R. Glowa, Megan Altemus, Trey Sunderland, Herbert Weingartner, Larry J. Siever and Lewis L. Judd. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.